TABLE 1.
Clinical and demographic data in the two study groups.
| Parameter | Group (1) control group (n = 30) | Group (2) atorvastatin group (n = 30) | p-value |
|---|---|---|---|
| Age (year) | 33.43 ± 5.93 | 35.13 ± 5.75 | 0.264 (t = 1.127, df = 58) |
| Sex (M/F) | 17/13 | 14/16 | 0.438 (χ2 = 0.6007) |
| Height (m2) | 1.661 ± 0.077 | 1.650 ± 0.064 | 0.542 (t = 0.6132, df = 58) |
| Weight (kg) | 65.27 ± 5.607 | 65.03 ± 5.216 | 0.868 (t = 0.1669, df = 58 |
| BMI (Kg/m2) | 23.65 ± 1.33 | 23.87 ± 0.957 | 0.471 (t = 0.7244, df = 58) |
| ALT (U/L) | 25.97 ± 4.664 | 27.47 ± 4.531 | 0.211 (t = 1.263, df = 58) |
| AST (U/L) | 29.43 ± 4.840 | 27.93 ± 4.291 | 0.209 (t = 1.270, df = 58) |
| SrCr (mg/dL) | 0.946 ± 0.134 | 0.963 ± 0.116 | 0.609 (t = 0.5132, df = 58) |
| Moderate depression | 12 (40%) | 10 (33.33%) | 0.715 (χ2 = 0.133) |
| Severe depression | 18 (60%) | 20 (66.66%) | 0.799 (χ2 = 0.064) |
Data are expressed as mean ± SD, numbers, and percentage, M: male, F: female, ALT: Alanine amino-transferase, AST: Aspartate amino-transferase, SrCr: Serum creatinine, BMI: body mass index, Significance at (p < 0.05).